Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Gladstone Land (LAND) Announces 1.15M Common Stock Offering
-
Gladstone Land Corporation Announces Common Stock Offering
-
Maxim Group Reiterats Bullish Stance on Galmed (GLMD) Following FDA Fast-Track Status; Funded Through Proof-of-Concept Studies in NASH
-
Maxim Group Calls Tekmira Pharma (TKMR) News 'Ground Breaking'
-
Pre-Open Stock Movers 9/19: (CNQR) (DRC) (JBLU) Higher; (ESI) (CRR) (TIBX) Lower (more...)
-
Quest Resource Holding (QRHC) Prices 9M Common Offering at $1.99/Share
-
Lpath (LPTN) Announces 3.6M Registered Direct Offering
-
After-Hours Stock Movers 9/18 (CNQR) (MCP) (JBLU) Higher; (TIBX) (RHT) (ORCL) Lower (more...)
-
Quest Resource Holding (QRHC) Reports Common Stock Offering
-
Foamix Pharmaceuticals (FOMX) IPO Opens Sharply Higher; Pauses on Volatility
-
Foamix Pharmaceuticals (FOMX) Prices 6.7M IPO at $6/Share
-
Maxim Group Starts SFX Entertainment (SFXE) at Buy
-
Maxim Group Starts VMware (VMW) at Buy
-
Maxim Group Starts U.S. Geothermal (HTM) at Buy
-
Unusual 11 Mid-Day Movers 9/8: (RADA) (MGAM) (BKYF) Higher; (VII) (ESYS) (DGLY) Lower
-
Maxim Group Starts ContraFect Corporation (CFRXU) at Buy
-
Unusual 11 Mid-Day Movers 9/5: (IVAN) (ANAD) (PRAN) Higher; (REPH) (ZQK) (AUMN) Lower
-
Notable Analyst Rating Changes 9/5: (IPCI) (CIEN) (BP) Upgraded; (TTWO) (PCLN) (MS) Downgraded
-
Pre-Open Stock Movers 9/5: (BLOX) (HURC) (AMBA) (LOCO) Higher; (REPH) (ZQK) (GPS) Lower (more...)
-
Maxim Group Upgrades IntelliPharmaCeutics International (IPCI) to Buy
-
Notable Analyst Rating Changes 9/4: (DHI) (IACI) (INFI) Upgraded; (LVS) (GPRO) (TNGO) Downgraded
-
Maxim Group Starts Enservco Corporation (ENSV) at Buy
-
Notable Analyst Rating Changes 9/3: (LL) (JPM) (KSS) Upgraded; (FTR) (SIR) (ALR) Downgraded
-
Maxim Group Upgrades Capstead Mortgage (CMO) to Buy
-
Maxim Group Downgrades CYS Investments (CYS) to Hold
-
Maxim Group Upgrades Kohl's (KSS) to Buy
-
Maxim Group Downgrades Chico's, Inc. (CHS) to Hold
-
Matters Regarding UBIC's Acquisition of Shares of TechLaw Solutions, Inc. (to be Our Subsidiary)
-
Keryx Biopharma (KERX) Ramps on Positive Sentiment Ahead of Sept 7 PDUFA Date
-
Keryx Biopharmaceuticals (KERX) a Buy Ahead of PDUFA Date, Maxim Group Said
-
Urban Outfitters (URBN) PT Lifted at Maxim Group, 'Hold' Maintained
-
Fifth Street Senior Floating Rate Corp. Raises $294.3 Million in Gross Proceeds in Connection With Public Offering of Common Stock
-
Maxim Group Remains Below the Street on Urban Outfitters (URBN) Into Q2 Print
-
Achillion (ACHN) Bullish Stance Reiterated at Maxim Group on Progress for HCV Candidates ACH-3422 and ACH-3102
-
Notable Analyst Rating Changes 8/15: (SHOO) (FANG) (MBI) Upgraded; (EXXI) (OVTI) (APO) Downgraded
-
Maxim Group Starts Virtusa (VRTU) at Buy
-
Maxim Group Starts iGATE (IGTE) at Buy
-
Notable Analyst Rating Changes 8/14: (JAKK) (NTAP) (PGR) Upgraded; (SEAS) (FN) (ITMN) Downgraded
-
FSFR (FSFR) 22.8M Offering Prices at $12.91/Share
-
Fifth Street Senior Floating Rate (FSFR) Prices 22.8M Common Offering at $12.91/Share
-
Fifth Street Senior Floating Rate Corp. Prices Public Offering of Common Stock
-
Maxim Group Starts IAC/InterActiveCorp (IACI) at Buy
-
Maxim Group Starts The KEYW Holding Corporation (KEYW) at Buy
-
Maxim Group Starts Engility Holdings, Inc. (EGL) at Buy
-
Maxim Group Analyst Discusses Ebola Virus (TKMR) (CYTX)
-
Streetinsider.com's Hot Lunchtime Reads 08/08: (LEAF) (MSFT) (MDVN) (XCO) (CMLS)
-
Medivation (MDVN) Rips on Strong Xtandi; Maxim Group Still Sees Significant Potential
-
Maxim Group Reiterates Buy Rating and $23 PT on Tekmira Pharma (TKMR) as FDA Partially Lifts Hold
-
Notable Analyst Rating Changes 08/05: (LO) (HIMX) (SMA) Upgraded; (ESI) (OCN) (LRN) Downgraded
-
Maxim Group Assumes Coveraege on Teva Pharma (TEVA) at Buy

